Abstract:
Introduction. Zoonotic cutaneous leishmaniasis has been known in Tunisia since the late 19th century. It represents a major public health problem in Methouia and Menzel Habib (Gabes Governorate). Epidemic Outbreaks of cutaneous leishmaniasis have occurred over the last five years. In 2024, cutaneous leishmaniasis experienced a reactivation in previously affected areas, with the appearance of new foci Aim of the study. The aim of this study is to establish the epidemiological and clinical profile of this leishmaniasis in light of the peak recorded in 2024. Methods and materials. This is a retrospective study including all cases of cutaneous leishmaniasis recruited at our outpatient departments from January 2024 to December 2024, which were analyzed specifying age, gender, origin of the disease, clinical appearance of the lesions, date of onset, duration of evolution, biological and/or histological confirmation, treatment, and progression. Results. A total of 235 cases were analyzed, with a sex ratio equal to 1 and a mean age of 25 years. The average duration of the lesion evolution was 3 months. Lesions were located on the face in 31 cases and on the limbs in 213 cases. Ulcerocrusted lesions predominated in 150 cases. Direct parasitological examination was positive in all cases. The lesions were cicatricial in 148 cases and progressive in 87. Intramuscular administration of Glucantime was administered for patients with multiple lesions or lesions located on the face or periarticular area. Patients with a lesion that was not superinfected and located outside the face received treatment via the intradermal route. Conclusions. Given the current epidemic context, we must establish an effective prophylactic strategy and offer appropriate treatment before the lesions evolve into cicatricial forms.